Case Report: The rare pancreatic involvement in Erdheim-Chester disease
This case highlights the diagnostic challenges of pancreatic ECD and underscores the critical value of an integrated approach-including imaging, immunohistochemistry, and molecular analysis-in achieving timely diagnosis. Early recognition and targeted therapy may significantly improve outcomes for patients with BRAF-mutant ECD.
Authors
- Jing Zhang (ORCID: https://orcid.org/0000-0001-5305-6233)
- Yadan Zou
- Ming Zhang (ORCID: https://orcid.org/0000-0003-0794-2546)
- Tao Li (ORCID: https://orcid.org/0000-0001-5080-3352)
- Sheng‐Guang Li (ORCID: https://orcid.org/0000-0002-8047-9984)
- Li Ji (ORCID: https://orcid.org/0000-0003-1878-6585)
- Juanjuan Song (ORCID: https://orcid.org/0000-0002-6550-6294)
Institutions
- Peking University (CN)
- Peking University International Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-07-14
- DOI
- https://doi.org/10.3389/fimmu.2025.1611452
- Primary Topic
- Histiocytic Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00